| Pegylated liposomal doxorubicin and carboplatin compared with paclitaxel and carboplatin for patients with platinum-sensitive ovarian cancer in late relapse E Pujade-Lauraine, U Wagner, E Aavall-Lundqvist, V Gebski, M Heywood, ... Journal of Clinical Oncology 28 (20), 3323-3329, 2010 | 736 | 2010 |
| Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study A Pearce, M Haas, R Viney, SA Pearson, P Haywood, C Brown, R Ward PloS one 12 (10), e0184360, 2017 | 636 | 2017 |
| Impact of EGFR inhibitor in non–small cell lung cancer on progression-free and overall survival: a meta-analysis CK Lee, C Brown, RJ Gralla, V Hirsh, S Thongprasert, CM Tsai, EH Tan, ... Journal of the National Cancer Institute 105 (9), 595-605, 2013 | 626 | 2013 |
| Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of … CL Vale, D Fisher, A Kneebone, C Parker, M Pearse, P Richaud, ... The Lancet 396 (10260), 1422-1431, 2020 | 339 | 2020 |
| Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial A Kneebone, C Fraser-Browne, GM Duchesne, R Fisher, M Frydenberg, ... The Lancet Oncology 21 (10), 1331-1340, 2020 | 298 | 2020 |
| Disease-free survival and local recurrence after laparoscopic-assisted resection or open resection for rectal cancer: the Australasian laparoscopic cancer of the rectum … ARL Stevenson, MJ Solomon, CSB Brown, JW Lumley, P Hewett, ... Annals of surgery 269 (4), 596-602, 2019 | 270 | 2019 |
| Comorbidity, age of onset and suicidality in obsessive–compulsive disorder (OCD): An international collaboration V Brakoulias, V Starcevic, A Belloch, C Brown, YA Ferrao, LF Fontenelle, ... Comprehensive psychiatry 76, 79-86, 2017 | 252 | 2017 |
| Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian … U Wagner, C Marth, R Largillier, J Kaern, C Brown, M Heywood, ... British journal of cancer 107 (4), 588-591, 2012 | 239 | 2012 |
| Rates of obstetric intervention among low-risk women giving birth in private and public hospitals in NSW: a population-based descriptive study HG Dahlen, S Tracy, M Tracy, A Bisits, C Brown, C Thornton BMJ open 2 (5), 2012 | 200 | 2012 |
| Markers of systemic inflammation predict survival in patients with advanced renal cell cancer P Fox, M Hudson, C Brown, S Lord, V Gebski, P De Souza, CK Lee British journal of cancer 109 (1), 147-153, 2013 | 193 | 2013 |
| Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in AK Nowak, WJ Lesterhuis, PS Kok, C Brown, BGM Hughes, DJ Karikios, ... The Lancet Oncology 21 (9), 1213-1223, 2020 | 170 | 2020 |
| Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma KM Field, J Simes, AK Nowak, L Cher, H Wheeler, EJ Hovey, CSB Brown, ... Neuro-oncology 17 (11), 1504-1513, 2015 | 165 | 2015 |
| Association of Surgical Skill Assessment With Clinical Outcomes in Cancer Surgery NJ Curtis, JD Foster, D Miskovic, CSB Brown, PJ Hewett, S Abbott, ... JAMA Surgery, 2020 | 146 | 2020 |
| Stereotactic body radiotherapy for oligometastatic prostate cancer detected via prostate-specific membrane antigen positron emission tomography A Kneebone, G Hruby, H Ainsworth, K Byrne, C Brown, L Guo, A Guminski, ... European urology oncology 1 (6), 531-537, 2018 | 126 | 2018 |
| Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy S Ananda, AK Nowak, L Cher, A Dowling, C Brown, J Simes, ... Journal of Clinical Neuroscience, 2011 | 121 | 2011 |
| Smoking at diagnosis is an independent prognostic factor for cancer-specific survival in head and neck cancer: findings from a large, population-based study L Sharp, J McDevitt, AE Carsin, C Brown, H Comber Cancer Epidemiology and Prevention Biomarkers 23 (11), 2579-2590, 2014 | 118 | 2014 |
| A randomized, phase III study of carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in relapsed platinum-sensitive ovarian cancer (OC): CALYPSO … E Pujade-Lauraine, S Mahner, J Kaern, V Gebski, M Heywood, P Vasey, ... J Clin Oncol 27 (18 Suppl), 799s, 2009 | 101 | 2009 |
| Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes KL Ong, KA Rye, R O'connell, AJ Jenkins, C Brown, A Xu, DR Sullivan, ... The Journal of Clinical Endocrinology & Metabolism 97 (12), 4701-4708, 2012 | 92 | 2012 |
| Rates of obstetric intervention and associated perinatal mortality and morbidity among low-risk women giving birth in private and public hospitals in NSW (2000–2008): a linked … CT Hannah G Dahlen, Sally Tracy, Mark Tracy, Andrew BMJ Open 4 (5), 2014 | 85 | 2014 |
| Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the … L Gladieff, A Ferrero, G De Rauglaudre, C Brown, P Vasey, A Reinthaller, ... Annals of Oncology, 2011 | 77 | 2011 |
Val GebskiNHMRC Clinical TRials Centre, University of SydneyVerifierad e-postadress på ctc.usyd.edu.au
